FDA recall record

Belmora Flanax recall — FDA D-136-2013

Defective Container: Product lacks tamper evident breakaway band on cap.

Class IIIclassification
D-136-2013official record ID
Jan 30, 2013report date

Recall record at a glance

Official recordD-136-2013
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBelmora LLC
Report dateJan 30, 2013
Recall initiation dateDec 18, 2012
Quantity17,996 bottles
LocationArlington, VA, United States

Official product description

Flanax (aluminum hydroxide, magnesium hydroxide, and simethicone) Fast Acting Antacid, 200 mg/200 mg/20 mg, 12 fl oz (355 mL) bottles, Distributed by: Belmora LLC, PO Box 3063, Arlington, VA 22203, UPC 8 53030 00209 0, NDC 27854.101.01.

Why the product was recalled

Defective Container: Product lacks tamper evident breakaway band on cap.

Distribution information

Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.